Related Experiment Video
Updated: Feb 25, 2026

12:17
Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots
Published on: May 21, 2017
11.9K
Balloon-Expandable Versus Self-Expanding Valves in Low-Flow, Low-Gradient Aortic Stenosis: Does Valve Type Matter?
Nav Warraich1, James A Brown1, Abbad Sultan1
1Department of Cardiothoracic Surgery, Division of Cardiac Surgery, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Summary
For patients with low-flow low-gradient aortic stenosis undergoing TAVR, balloon-expandable (BE) and self-expanding (SE) transcatheter heart valves (THVs) show similar survival. BE THVs may reduce heart failure readmissions.
Area of Science:
- Cardiology
- Interventional Cardiology
- Cardiac Surgery
Background:
- Low-flow low-gradient aortic stenosis (LFLG AS) poses treatment challenges.
- The choice between balloon-expandable (BE) and self-expanding (SE) transcatheter heart valves (THVs) for TAVR in LFLG AS is not well-defined.
Purpose of the Study:
- To compare the clinical outcomes of BE THVs versus SE THVs in patients with LFLG AS undergoing TAVR.
- To assess differences in survival and heart failure readmission rates between BE and SE THV groups.
Main Methods:
- Retrospective cohort study of 732 patients with LFLG AS undergoing TAVR (2012-2024).
- Patients were stratified by THV type: BE (n=478) or SE (n=254).
- Outcomes including mortality, gradients, paravalvular leak, survival (Kaplan-Meier, Cox regression), and heart failure readmission (cumulative incidence, Cox regression) were analyzed.
Main Results:
- No significant difference in 30-day mortality or midterm survival between BE and SE THV groups.
- SE THVs showed a lower mean gradient post-TAVR but higher rates of paravalvular leak at 30 days.
- BE THVs were associated with a reduced hazard of heart failure readmission (HR 0.77, p=0.04) on multivariable analysis.
Conclusions:
- Both BE and SE THVs offer comparable midterm survival for LFLG AS patients undergoing TAVR.
- Balloon-expandable THVs demonstrate a potential benefit in reducing heart failure readmissions in this patient population.

